{"entity":{"type":"insider","cik":"0001847529","url":"/insider/0001847529","json_url":"/insider/0001847529.json","name":"Liu Joy","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":31,"n_filings":12,"first":"2021-03-08","last":"2026-07-06","span_basis":"filed_date"},"name_variants":[{"name":"Liu Joy","source":"filing","n_filings":12,"first_seen":"2021-03-08","last_seen":"2026-07-06"}],"transactions":[{"id":5780739,"accession":"0000875320-26-000241","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-26-000241","line_url":"/filing/0000875320-26-000241#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001847529","owner_name":"Liu Joy","owner_url":"/insider/0001847529","role":"Officer (EVP and Chief Legal Officer)","officer_title":"EVP and Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":828.0,"shares_display":"828","price_per_share":502.71,"price_display":"502.71","price_state":"stated","total_value":416243.88,"total_display":"416,243.88","shares_owned_after":19131.0,"shares_owned_after_display":"19,131","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-01","filed_date":"2026-07-06","scope":"insider"},{"id":5831919,"accession":"0000875320-26-000230","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-26-000230","line_url":"/filing/0000875320-26-000230#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001847529","owner_name":"Liu Joy","owner_url":"/insider/0001847529","role":"Officer (EVP and Chief Legal Officer)","officer_title":"EVP and Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":828.0,"shares_display":"828","price_per_share":439.91,"price_display":"439.91","price_state":"stated","total_value":364245.48,"total_display":"364,245.48","shares_owned_after":19959.0,"shares_owned_after_display":"19,959","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-01","filed_date":"2026-06-03","scope":"insider"},{"id":5794491,"accession":"0000875320-26-000183","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-26-000183","line_url":"/filing/0000875320-26-000183#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001847529","owner_name":"Liu Joy","owner_url":"/insider/0001847529","role":"Officer (EVP and Chief Legal Officer)","officer_title":"EVP and Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1104.0,"shares_display":"1,104","price_per_share":425.02,"price_display":"425.02","price_state":"stated","total_value":469222.08,"total_display":"469,222.08","shares_owned_after":20729.0,"shares_owned_after_display":"20,729","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-01","filed_date":"2026-05-05","scope":"insider"},{"id":6145550,"accession":"0000875320-26-000157","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-26-000157","line_url":"/filing/0000875320-26-000157#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001847529","owner_name":"Liu Joy","owner_url":"/insider/0001847529","role":"Officer (EVP and Chief Legal Officer)","officer_title":"EVP and Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":978.0,"shares_display":"978","price_per_share":449.17,"price_display":"449.17","price_state":"stated","total_value":439288.26,"total_display":"439,288.26","shares_owned_after":21833.0,"shares_owned_after_display":"21,833","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-01","filed_date":"2026-04-03","scope":"insider"},{"id":5854759,"accession":"0000875320-26-000134","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-26-000134","line_url":"/filing/0000875320-26-000134#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001847529","owner_name":"Liu Joy","owner_url":"/insider/0001847529","role":"Officer (EVP and Chief Legal Officer)","officer_title":"EVP and Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":892.0,"shares_display":"892","price_per_share":495.96,"price_display":"495.96","price_state":"stated","total_value":442396.32,"total_display":"442,396.32","shares_owned_after":22811.0,"shares_owned_after_display":"22,811","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":6117760,"accession":"0000899243-22-029023","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-22-029023","line_url":"/filing/0000899243-22-029023#line-6","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001847529","owner_name":"Liu Joy","owner_url":"/insider/0001847529","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1743.0,"shares_display":"1,743","price_per_share":305.01,"price_display":"305.01","price_state":"stated","total_value":531632.43,"total_display":"531,632.43","shares_owned_after":9905.0,"shares_owned_after_display":"9,905","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-15","filed_date":"2022-08-17","scope":"insider"},{"id":6117757,"accession":"0000899243-22-029023","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-22-029023","line_url":"/filing/0000899243-22-029023#line-5","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001847529","owner_name":"Liu Joy","owner_url":"/insider/0001847529","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":303.99,"price_display":"303.99","price_state":"stated","total_value":212793.0,"total_display":"212,793.00","shares_owned_after":11648.0,"shares_owned_after_display":"11,648","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-15","filed_date":"2022-08-17","scope":"insider"},{"id":6117755,"accession":"0000899243-22-029023","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-029023","line_url":"/filing/0000899243-22-029023#line-4","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001847529","owner_name":"Liu Joy","owner_url":"/insider/0001847529","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":698.0,"shares_display":"698","price_per_share":301.63,"price_display":"301.63","price_state":"stated","total_value":210537.74,"total_display":"210,537.74","shares_owned_after":12448.0,"shares_owned_after_display":"12,448","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-15","filed_date":"2022-08-17","scope":"insider"},{"id":6117752,"accession":"0000899243-22-029023","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-029023","line_url":"/filing/0000899243-22-029023#line-3","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001847529","owner_name":"Liu Joy","owner_url":"/insider/0001847529","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":305.57,"price_display":"305.57","price_state":"stated","total_value":91671.0,"total_display":"91,671.00","shares_owned_after":9605.0,"shares_owned_after_display":"9,605","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-15","filed_date":"2022-08-17","scope":"insider"},{"id":6117749,"accession":"0000899243-22-029023","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-029023","line_url":"/filing/0000899243-22-029023#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001847529","owner_name":"Liu Joy","owner_url":"/insider/0001847529","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":206.0,"shares_display":"206","price_per_share":300.26,"price_display":"300.26","price_state":"stated","total_value":61853.56,"total_display":"61,853.56","shares_owned_after":13146.0,"shares_owned_after_display":"13,146","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-15","filed_date":"2022-08-17","scope":"insider"},{"id":6117745,"accession":"0000899243-22-029023","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-029023","line_url":"/filing/0000899243-22-029023#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001847529","owner_name":"Liu Joy","owner_url":"/insider/0001847529","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":302.35,"price_display":"302.35","price_state":"stated","total_value":30235.0,"total_display":"30,235.00","shares_owned_after":12348.0,"shares_owned_after_display":"12,348","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-15","filed_date":"2022-08-17","scope":"insider"},{"id":6140216,"accession":"0000899243-22-028470","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-028470","line_url":"/filing/0000899243-22-028470#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001847529","owner_name":"Liu Joy","owner_url":"/insider/0001847529","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36.0,"shares_display":"36","price_per_share":300.32,"price_display":"300.32","price_state":"stated","total_value":10811.52,"total_display":"10,811.52","shares_owned_after":13352.0,"shares_owned_after_display":"13,352","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-10","filed_date":"2022-08-12","scope":"insider"},{"id":6364817,"accession":"0000899243-22-028249","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-028249","line_url":"/filing/0000899243-22-028249#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001847529","owner_name":"Liu Joy","owner_url":"/insider/0001847529","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":946.0,"shares_display":"946","price_per_share":300.0,"price_display":"300.00","price_state":"stated","total_value":283800.0,"total_display":"283,800.00","shares_owned_after":13388.0,"shares_owned_after_display":"13,388","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-09","filed_date":"2022-08-10","scope":"insider"},{"id":6877295,"accession":"0000899243-22-018604","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-22-018604","line_url":"/filing/0000899243-22-018604#line-5","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001847529","owner_name":"Liu Joy","owner_url":"/insider/0001847529","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35.0,"shares_display":"35","price_per_share":254.36,"price_display":"254.36","price_state":"stated","total_value":8902.6,"total_display":"8,902.60","shares_owned_after":14334.0,"shares_owned_after_display":"14,334","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-16","filed_date":"2022-05-18","scope":"insider"},{"id":6877290,"accession":"0000899243-22-018604","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-018604","line_url":"/filing/0000899243-22-018604#line-4","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001847529","owner_name":"Liu Joy","owner_url":"/insider/0001847529","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34.0,"shares_display":"34","price_per_share":253.87,"price_display":"253.87","price_state":"stated","total_value":8631.58,"total_display":"8,631.58","shares_owned_after":14369.0,"shares_owned_after_display":"14,369","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-16","filed_date":"2022-05-18","scope":"insider"},{"id":6877280,"accession":"0000899243-22-018604","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-018604","line_url":"/filing/0000899243-22-018604#line-3","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001847529","owner_name":"Liu Joy","owner_url":"/insider/0001847529","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25.0,"shares_display":"25","price_per_share":250.77,"price_display":"250.77","price_state":"stated","total_value":6269.25,"total_display":"6,269.25","shares_owned_after":14442.0,"shares_owned_after_display":"14,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-16","filed_date":"2022-05-18","scope":"insider"},{"id":6877276,"accession":"0000899243-22-018604","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-018604","line_url":"/filing/0000899243-22-018604#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001847529","owner_name":"Liu Joy","owner_url":"/insider/0001847529","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20.0,"shares_display":"20","price_per_share":252.49,"price_display":"252.49","price_state":"stated","total_value":5049.8,"total_display":"5,049.80","shares_owned_after":14403.0,"shares_owned_after_display":"14,403","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-16","filed_date":"2022-05-18","scope":"insider"},{"id":6877274,"accession":"0000899243-22-018604","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-018604","line_url":"/filing/0000899243-22-018604#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001847529","owner_name":"Liu Joy","owner_url":"/insider/0001847529","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19.0,"shares_display":"19","price_per_share":251.57,"price_display":"251.57","price_state":"stated","total_value":4779.83,"total_display":"4,779.83","shares_owned_after":14423.0,"shares_owned_after_display":"14,423","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-16","filed_date":"2022-05-18","scope":"insider"},{"id":6385977,"accession":"0000899243-22-016320","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-22-016320","line_url":"/filing/0000899243-22-016320#line-5","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001847529","owner_name":"Liu Joy","owner_url":"/insider/0001847529","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41.0,"shares_display":"41","price_per_share":274.75,"price_display":"274.75","price_state":"stated","total_value":11264.75,"total_display":"11,264.75","shares_owned_after":14396.0,"shares_owned_after_display":"14,396","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-29","filed_date":"2022-05-03","scope":"insider"},{"id":6385973,"accession":"0000899243-22-016320","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-016320","line_url":"/filing/0000899243-22-016320#line-4","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001847529","owner_name":"Liu Joy","owner_url":"/insider/0001847529","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30.0,"shares_display":"30","price_per_share":275.62,"price_display":"275.62","price_state":"stated","total_value":8268.6,"total_display":"8,268.60","shares_owned_after":14366.0,"shares_owned_after_display":"14,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-29","filed_date":"2022-05-03","scope":"insider"},{"id":6385971,"accession":"0000899243-22-016320","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-016320","line_url":"/filing/0000899243-22-016320#line-3","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001847529","owner_name":"Liu Joy","owner_url":"/insider/0001847529","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22.0,"shares_display":"22","price_per_share":276.72,"price_display":"276.72","price_state":"stated","total_value":6087.84,"total_display":"6,087.84","shares_owned_after":14344.0,"shares_owned_after_display":"14,344","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-29","filed_date":"2022-05-03","scope":"insider"},{"id":6385969,"accession":"0000899243-22-016320","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-016320","line_url":"/filing/0000899243-22-016320#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001847529","owner_name":"Liu Joy","owner_url":"/insider/0001847529","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17.0,"shares_display":"17","price_per_share":273.37,"price_display":"273.37","price_state":"stated","total_value":4647.29,"total_display":"4,647.29","shares_owned_after":14437.0,"shares_owned_after_display":"14,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-29","filed_date":"2022-05-03","scope":"insider"},{"id":6385965,"accession":"0000899243-22-016320","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-016320","line_url":"/filing/0000899243-22-016320#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001847529","owner_name":"Liu Joy","owner_url":"/insider/0001847529","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10.0,"shares_display":"10","price_per_share":278.04,"price_display":"278.04","price_state":"stated","total_value":2780.4,"total_display":"2,780.40","shares_owned_after":14334.0,"shares_owned_after_display":"14,334","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-29","filed_date":"2022-05-03","scope":"insider"},{"id":5160661,"accession":"0001209191-21-033986","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-033986","line_url":"/filing/0001209191-21-033986#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001847529","owner_name":"Liu Joy","owner_url":"/insider/0001847529","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65.0,"shares_display":"65","price_per_share":215.95,"price_display":"215.95","price_state":"stated","total_value":14036.75,"total_display":"14,036.75","shares_owned_after":8300.0,"shares_owned_after_display":"8,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-17","filed_date":"2021-05-19","scope":"insider"},{"id":5160654,"accession":"0001209191-21-033986","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-033986","line_url":"/filing/0001209191-21-033986#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001847529","owner_name":"Liu Joy","owner_url":"/insider/0001847529","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47.0,"shares_display":"47","price_per_share":216.88,"price_display":"216.88","price_state":"stated","total_value":10193.36,"total_display":"10,193.36","shares_owned_after":8253.0,"shares_owned_after_display":"8,253","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-17","filed_date":"2021-05-19","scope":"insider"},{"id":4984410,"accession":"0001209191-21-018528","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-21-018528","line_url":"/filing/0001209191-21-018528#line-6","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001847529","owner_name":"Liu Joy","owner_url":"/insider/0001847529","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1460.0,"shares_display":"1,460","price_per_share":211.67,"price_display":"211.67","price_state":"stated","total_value":309038.2,"total_display":"309,038.20","shares_owned_after":8509.0,"shares_owned_after_display":"8,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-05","filed_date":"2021-03-08","scope":"insider"},{"id":4984406,"accession":"0001209191-21-018528","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-018528","line_url":"/filing/0001209191-21-018528#line-5","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001847529","owner_name":"Liu Joy","owner_url":"/insider/0001847529","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1351.0,"shares_display":"1,351","price_per_share":207.57,"price_display":"207.57","price_state":"stated","total_value":280427.07,"total_display":"280,427.07","shares_owned_after":12043.0,"shares_owned_after_display":"12,043","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-05","filed_date":"2021-03-08","scope":"insider"},{"id":4984400,"accession":"0001209191-21-018528","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-018528","line_url":"/filing/0001209191-21-018528#line-4","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001847529","owner_name":"Liu Joy","owner_url":"/insider/0001847529","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1119.0,"shares_display":"1,119","price_per_share":208.39,"price_display":"208.39","price_state":"stated","total_value":233188.41,"total_display":"233,188.41","shares_owned_after":10924.0,"shares_owned_after_display":"10,924","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-05","filed_date":"2021-03-08","scope":"insider"},{"id":4984393,"accession":"0001209191-21-018528","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-018528","line_url":"/filing/0001209191-21-018528#line-3","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001847529","owner_name":"Liu Joy","owner_url":"/insider/0001847529","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":844.0,"shares_display":"844","price_per_share":210.64,"price_display":"210.64","price_state":"stated","total_value":177780.16,"total_display":"177,780.16","shares_owned_after":9969.0,"shares_owned_after_display":"9,969","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-05","filed_date":"2021-03-08","scope":"insider"},{"id":4984383,"accession":"0001209191-21-018528","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-018528","line_url":"/filing/0001209191-21-018528#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001847529","owner_name":"Liu Joy","owner_url":"/insider/0001847529","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":256.0,"shares_display":"256","price_per_share":212.28,"price_display":"212.28","price_state":"stated","total_value":54343.68,"total_display":"54,343.68","shares_owned_after":8253.0,"shares_owned_after_display":"8,253","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-05","filed_date":"2021-03-08","scope":"insider"},{"id":4984373,"accession":"0001209191-21-018528","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-018528","line_url":"/filing/0001209191-21-018528#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001847529","owner_name":"Liu Joy","owner_url":"/insider/0001847529","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":111.0,"shares_display":"111","price_per_share":209.37,"price_display":"209.37","price_state":"stated","total_value":23240.07,"total_display":"23,240.07","shares_owned_after":10813.0,"shares_owned_after_display":"10,813","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-05","filed_date":"2021-03-08","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":31,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":31,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":31},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000875320","name":"VERTEX PHARMACEUTICALS INC / MA","url":"/issuer/0000875320","role":"Officer (EVP and Chief Legal Officer)","n_filings":12,"first_seen":"2021-03-08","last_seen":"2026-07-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001847529","retrieved_at":"2026-08-21T20:26:23+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}